EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma

Maxwell Y Lee, Alistaire R Sherman, Luis Martinez Ramirez, Mobeen Rahman, Sabrina Zdravkovic, June Ho Shin, Ivan Stepanek, Alexander Dimitrios Colevas, John B Sunwoo, Vasu Divi

Journal for ImmunoTherapy of Cancer · 2026-01 · 14 (1) · e014067

DOI: 10.1136/jitc-2025-014067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 30.01.2026. Verfasst von Maxwell Y Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Cutaneous Squamous Cell Carcinoma, Skin Neoplasms, Programmed Cell Death 1 Receptor, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDCR NIH HHS, Regeneron, Genentech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neoadjuvant PD-1/PD-L1 blockade yields robust efficacy in advanced cutaneous squamous cell carcinoma (cSCC), yet many patients fail to achieve a complete or major pathologic response. The reasons why some patients experience response but others do not are unclear.

Methods

We profiled cSCC specimens before, after 1 dose, and after 3–4 doses of PD-1/PD-L1 blockade to uncover resistance mechanisms and predict therapeutic response. In total, 27 patients across three cohorts, including two phase II trials, were studied. We created 1.7 mm tissue-core microarrays and performed single-cell spatial transcriptomics, including spatial clustering, gene-set enrichment, and spatial correlation analyses.

Results

After profiling all samples, six distinct spatial niches emerged, each differentially enriched in responders versus non-responders. A high antigen presentation niche, B/plasma cell enriched niche, and inflammatory keratinocyte niche were more frequent in responders, whereas proliferative keratinocyte, low antigen presentation myeloid, and fibroblast-rich epithelial–mesenchymal transition niches prevailed in non-responders. Notably, spatial niche profiling on pretreatment samples outperformed PD-L1 status in predicting pathologic response. Each niche displayed unique gene coexpression modules, suggesting niche-specific resistance mechanisms. Individual tumor analyses revealed varied immune evasion strategies, including defective interferon-induced antigen presentation, immunosuppressive myeloid environments, and epithelial–mesenchymal transition.

Conclusions

Our single-cell spatial transcriptomic approach identifies six spatial niches that predict immunotherapy response better than PD-L1 status using only 1.7 mm tissue cores and may inform the development of biomarkers. Our results further underscore the heterogeneity of resistance mechanisms among cSCC patients, highlighting the need for tailored therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cutaneous Squamous Cell CarcinomaSkin NeoplasmsProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsB7-H1 AntigenCarcinoma, Squamous CellHumansSpatial TranscriptomicsTumor MicroenvironmentFemaleSingle-Cell Gene Expression AnalysisMale

Stichwörter der Autor:innen

Immune Checkpoint InhibitorImmunotherapySkin Cancer

Substanzen

Programmed Cell Death 1 ReceptorImmune Checkpoint InhibitorsB7-H1 AntigenPDCD1 protein, humanCD274 protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA.
  • Stanford Cancer Institute Clinical Trials Office, Stanford University School of Medicine, Palo Alto, California, USA.
  • Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.
  • Department of Medicine, Division of Medical Oncology, Stanford University, Palo Alto, California, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA vdivi@stanford.edu sunwoo@stanford.edu.

Förderung

  • NIDCR NIH HHS
  • Regeneron
  • Genentech
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Lee, M. Y., Sherman, A. R., Martinez Ramirez, L., Rahman, M., Zdravkovic, S., Shin, J. H., Stepanek, I., Colevas, A. D., Sunwoo, J. B., & Divi, V. (2026). Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. Journal for ImmunoTherapy of Cancer, 14(1), e014067. https://doi.org/10.1136/jitc-2025-014067

Vancouver

Lee MY, Sherman AR, Martinez Ramirez L, Rahman M, Zdravkovic S, Shin JH, et al. Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 2026;14(1):e014067. doi:10.1136/jitc-2025-014067

BibTeX
@article{Lee2026,
  author = {Lee, Maxwell Y and Sherman, Alistaire R and Martinez Ramirez, Luis and Rahman, Mobeen and Zdravkovic, Sabrina and Shin, June Ho and Stepanek, Ivan and Colevas, Alexander Dimitrios and Sunwoo, John B and Divi, Vasu},
  title = {Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {1},
  pages = {e014067},
  doi = {10.1136/jitc-2025-014067}
}
Kostenlos starten →